Back to the main directory
Company Analysis / Equity
- ELIOR. Caution on the first half by MidCap Partners
- ID LOGISTICS. Tempting, but no! by MidCap Partners
- Keppel's One-Off Fine Is Blow to Reputation, but Financial Impact Limited by Morningstar
- Moncler's Brand Drives a Narrow Moat, but Shares Look Expensive Relative to Our EUR 21 FVE by Morningstar
- Downgrade to Neutral by Atlantic Equities
- Accrol PLC* (ACRL LN) by Zeus Capital
- Secure Trust Bank - Controlled growth by Edison Investment Research
- CIS Market Daily - January 22, 2018 by Sberbank
- Upgrading Fox to O/W as best way to play Disney by Atlantic Equities
- Opportunity on recent pullback by Atlantic Equities
- Fracc margins slip, Drill & Eval. margins jump by Atlantic Equities
- Mail.ru Group - Выход в Ñегмент киберÑпорта: Ñобытие ожидаемое, позитивно Ð´Ð»Ñ ÐºÐ¾Ð¼Ð¿Ð°Ð½Ð¸Ð¸ by Sberbank
- Adding further complexity for little upside by Atlantic Equities
- Flowtech Fluidpower Plc* (FLO LN) by Zeus Capital
- CIS Market Daily - 23 ÑÐ½Ð²Ð°Ñ€Ñ 2018 by Sberbank
- X5 Retail Group - Выручка в 4К17 выроÑла более чем на 23% by Sberbank
- Q4 snap: good result, premium growth strong by Atlantic Equities
- Mediobanca is a unique play on Italian financial services. by Morningstar
- Solid 4Q17/FY18 guide, questions on pharma by Atlantic Equities
- Celgene Corp. bietet für JUNO Therapeutics über US-$ 9 Mrd. – MDG1-Führungsprojekt vor Klinikstart by EQUITS GmbH
- PharmaMar - Zepsyre misses in Ovarian, SCLC still promising by Edison Investment Research
- Dropping Coverage of Flex by Morningstar
- Dropping Coverage of Zebra Technologies by Morningstar
- Dropping Coverage of CPFL by Morningstar
- Despite increasing Lantus competition, Sanofi's focus on steady business lines drives steady growth. by Morningstar